Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343902 · ClinicalTrials.gov registry record · Phase 3
Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial
A Phase 3 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT00343902 is a Phase 3 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 120 participants.
The verdict
NCT00343902, a Phase 3 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
To determine the effect of hawthorn extract 450 mg bid vs. placebo, in addition to standard medical therapy in ambulatory patients with NYHA class II to IV chronic heart failure on submaximal exercise as measured by the 6-minute walk test
Interventions
- DRUG Crataegus Special Extract WS 1442
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2000-01 |
| Est. Completion | 2004-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343902
The ClinicalTrials.gov registry entry for NCT00343902 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Crataegus Special Extract WS 1442 is the first listed.
NCT00343902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343902 about?
NCT00343902 is a clinical study titled "Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial". To determine the effect of hawthorn extract 450 mg bid vs. placebo, in addition to standard medical therapy in ambulatory patients with NYHA class II to IV chronic heart failure on submaximal exercise as measured by the 6-minute walk test
What is the current status of trial NCT00343902?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2000-01. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00343902?
The interventions under investigation include: Crataegus Special Extract WS 1442 (DRUG).
Who is sponsoring clinical trial NCT00343902?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.